Richard Bertz, Biohaven Pharmaceuticals
personal info
Dr. Richard (Rick) Bertz is currently Senior Vice President, Clinical Pharmacology and Pharmacometrics at Biohaven Pharmaceuticals. Dr. Bertz has worked in pharmaceutical industry for over 25 years, previously with Bristol-Myers Squibb, where he led the Clinical Pharmacology and Pharmacometrics Group and prior to that with Abbott Labs.
Dr. Bertz has been involved in all phases of clinical drug development, with a focus on the analysis and interpretation of clinical pharmacology and pharmacometric data. He has mentored, coached, managed, and developed numerous clinical pharmacologists and drug development scientists. Dr. Bertz has been integrally involved in the completion of components of NDA submissions that have led to worldwide regulatory approval for several antiviral drugs for treatment of HIV and HCV and a neuroscience drug for the treatment of migraine.
Dr. Bertz has coauthored over 80 peer-reviewed publications and given numerous invited presentations at national and international scientific meetings. He previously held a faculty appointment as Professor and Associate Dean at the University of Pittsburgh, School of Pharmacy, where he is currently an Adjunct Professor. Dr. Bertz received a BS in Pharmacy from the University of Wisconsin and earned his PhD from the University of Pittsburgh Clinical Pharmaceutical Scientist Graduate Program.